A detailed history of American Century Companies Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 36,060 shares of PTCT stock, worth $1.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,060
Previous 37,394 3.57%
Holding current value
$1.53 Million
Previous $1.14 Million 16.97%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$30.39 - $37.66 $40,540 - $50,238
-1,334 Reduced 3.57%
36,060 $1.34 Million
Q2 2024

Aug 07, 2024

BUY
$24.69 - $40.12 $480,837 - $781,337
19,475 Added 108.68%
37,394 $1.14 Million
Q1 2024

May 14, 2024

SELL
$24.15 - $31.95 $188,104 - $248,858
-7,789 Reduced 30.3%
17,919 $521,000
Q4 2023

Feb 13, 2024

BUY
$18.07 - $29.37 $464,543 - $755,043
25,708 New
25,708 $708,000
Q3 2023

Nov 13, 2023

BUY
$22.41 - $41.99 $32,696 - $61,263
1,459 Added 6.57%
23,650 $529,000
Q2 2023

Aug 14, 2023

BUY
$40.4 - $59.1 $549,803 - $804,291
13,609 Added 158.58%
22,191 $902,000
Q1 2023

May 11, 2023

BUY
$38.16 - $48.86 $20,797 - $26,628
545 Added 6.78%
8,582 $415,000
Q4 2022

Feb 13, 2023

SELL
$33.53 - $54.79 $281,886 - $460,619
-8,407 Reduced 51.13%
8,037 $306,000
Q3 2022

Nov 14, 2022

BUY
$41.85 - $53.85 $262,566 - $337,854
6,274 Added 61.69%
16,444 $825,000
Q2 2022

Aug 12, 2022

SELL
$25.6 - $45.23 $76,800 - $135,690
-3,000 Reduced 22.78%
10,170 $407,000
Q3 2021

Nov 10, 2021

BUY
$37.01 - $44.74 $487,421 - $589,225
13,170 New
13,170 $490,000
Q1 2021

May 14, 2021

SELL
$46.8 - $68.92 $471,697 - $694,644
-10,079 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$47.96 - $67.64 $144,359 - $203,596
-3,010 Reduced 23.0%
10,079 $615,000
Q3 2020

Nov 13, 2020

SELL
$45.41 - $57.07 $9.13 Million - $11.5 Million
-200,952 Reduced 93.88%
13,089 $612,000
Q2 2020

Aug 13, 2020

BUY
$42.56 - $54.98 $723,222 - $934,275
16,993 Added 8.62%
214,041 $10.9 Million
Q1 2020

May 14, 2020

BUY
$32.37 - $59.36 $345,485 - $633,549
10,673 Added 5.73%
197,048 $8.79 Million
Q4 2019

Feb 12, 2020

BUY
$32.22 - $50.07 $2.45 Million - $3.81 Million
76,061 Added 68.95%
186,375 $8.95 Million
Q3 2019

Nov 13, 2019

BUY
$33.82 - $48.17 $222,332 - $316,669
6,574 Added 6.34%
110,314 $3.73 Million
Q2 2019

Aug 14, 2019

BUY
$35.42 - $45.0 $3.67 Million - $4.67 Million
103,740 New
103,740 $4.67 Million
Q4 2018

Feb 13, 2019

SELL
$29.83 - $46.51 $2.07 Million - $3.23 Million
-69,384 Closed
0 $0
Q3 2018

Nov 02, 2018

SELL
$33.9 - $47.77 $768,106 - $1.08 Million
-22,658 Reduced 24.62%
69,384 $3.26 Million
Q1 2018

May 03, 2018

SELL
$17.46 - $32.59 $1.74 Million - $3.24 Million
-99,399 Reduced 51.92%
92,042 $2.49 Million
Q4 2017

Feb 02, 2018

SELL
$15.14 - $20.89 $79,954 - $110,320
-5,281 Reduced 2.68%
191,441 $3.19 Million
Q3 2017

Nov 01, 2017

BUY
$16.81 - $21.61 $3.31 Million - $4.25 Million
196,722
196,722 $3.94 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.03B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.